News Sentiment

TCRX sentiment intelligence

Tscan Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 58 Balanced news tone 49 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.91 Week of 17 Jul 2026
Weighted tone 58/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

75/100 classification confidence.

Company focus 40

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-16.1% over one week, -0.6% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

TScan Therapeutics, Inc. (TCRX) reports Q1 loss, lags revenue estimates

Market Reaction

Price moving ahead of tone

66/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 75/100 classification
One-week reaction -16.1% Price reacting lower
Trend fit Trend inactive -0.6% over four weeks
Fair value -72.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 20
Neutral 25
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 40
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 8
TradingView 7
Stock Titan 5
GlobeNewswire 3
Moomoo 3
Quartr 2
Investing.com 2
GuruFocus 2

Event Lens

What the news is about

Classified themes
Market update 20
Earnings 17
Analyst action 9
Guidance 3

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-49 of 49